Drug & supplement interaction

Bifidobacterium Breve + Temozolomide

Temozolomide brand name: Temodar.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Bifidobacterium Breve and Temozolomide in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Temozolomide states a food rule worth keeping to, and the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Bifidobacterium Breve and Temozolomide

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Temozolomide and Bifidobacterium Breve in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Bifidobacterium Breve safety at a glance

Bifidobacterium Br... overall Use caution Generally well tolerated in healthy people, but caution is needed for those who are very ill or immunocompromised.
Pregnancy Use caution Probiotics are often considered low-risk, but evidence is limited, so use only with your doctor's guidance.
Breastfeeding Use caution Limited safety data exist, so check with your healthcare provider before use.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Temozolomide and Bifidobacterium Breve? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Temozolomide

Interactions in our licensed database are recorded against drug classes, not just single drug names. Temozolomide is filed under 3 classifications — alkylating agents, antineoplastics, oral drugs. Bifidobacterium Breve has documented interactions with 1 drug class — the most serious being antibiotic drugs (moderate) — and none of Temozolomide’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Bifidobacterium Breve Does Interact With Other Medications

Bifidobacterium Breve has 182 moderate known drug interactions in our database — Temozolomide isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Bifidobacterium Breve

Covers the 2,830 medications we’ve checked against Bifidobacterium Breve. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Bifidobacterium Breve and Temozolomide May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. One of them is worth acting on rather than waiting out — marked below.

  • A higher chance of infection Worth acting on Additional detail

    Bifidobacterium Breve

    “There have been rare cases of Bifidobacterium bacteremia related to probiotic use in critically ill infants and adults. In addition, cases of B. breve bacteremia have occurred in preterm infants or young children using probiotics. In a review of 298 term and preterm infants who were admitted to the neonatal intensive care unit of a hospital in Japan and received B.”

    Bifidobacterium Breve · Natural Medicines adverse-effect record, reported in diabetes.

    6 sources cited
    1. 102416. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
    2. 107597. Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
    3. 107599. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
    4. 107596. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81. PubMed
    5. 111007. Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
    6. 111011. Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667. PubMed

    Temozolomide

    Listed in the ADVERSE REACTIONS section of the FDA label for Temozolomide. Read the label on DailyMed ›

Reported for Bifidobacterium Breve but not commonly for Temozolomide: bloating or gas and a bowel blockage.

Effects for Temozolomide come from the ADVERSE REACTIONS section of its FDA label; effects for Bifidobacterium Breve come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

How to take them

Some Temozolomide Products Have a Food Rule — Bifidobacterium Breve Should Not Break It

At least one FDA label for a product containing Temozolomide says to take it on an empty stomach. Most supplements — Bifidobacterium Breve included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Temozolomide on its own and move Bifidobacterium Breve to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Temozolomide products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

To reduce nausea and vomiting, take TEMODAR on an empty stomach or at bedtime and consider antiemetic therapy prior to and following TEMODAR administration.

From the Dosage and Administration section of the FDA label we read for Temozolomide — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

From our Q&A

Questions About Bifidobacterium Breve or Temozolomide

These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Bifidobacterium Breve or Temozolomide, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:

Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.

Everything else you take

See Every Supplement That Interacts With Temozolomide

This page covers Bifidobacterium Breve only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Temozolomide page lists 25 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Acerola (moderate), Alpha-lipoic Acid (moderate), Coenzyme Q10 (moderate) and Coffee Charcoal (moderate).

By severity: 1 major · 14 moderate · 10 minor.

From our pharmacist’s overview on the Temozolomide page

“Temozolomide (Temodar) is an oral chemotherapy pill, usually prescribed for aggressive brain tumors, and stakes that high make me treat this list with real caution. Most of the 25 supplements on file interfere in the gut, where fibers, gums, and charcoals may bind the drug or change how much of it gets absorbed.”

Reviewed by 2 · Jul 18, 2026

Open the Temozolomide interaction page

One more smart check

Taking Bifidobacterium Breve as Part of a Dietary Supplement Product? Check It for Interactions

We hold 1,771 real supplement products containing Bifidobacterium Breve, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Bifidobacterium Breve. Even though Bifidobacterium Breve itself has no known interaction with Temozolomide, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Bifidobacterium Breve and Temozolomide Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Bifidobacterium Breve
Top 25%

#208 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Temozolomide
Steady interest

#2,333 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Bifidobacterium Breve reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Bifidobacterium Breve and Temozolomide records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Bifidobacterium Breve

What is Bifidobacterium Breve?

  • Digestive health and regularity
  • Infant colic and gut support
  • Diarrhea (including antibiotic-related)
  • Constipation
  • General immune and gut microbiome support

Bifidobacterium breve is a 'friendly' gut bacterium taken as a probiotic, most often to support digestion and balance the gut microbiome. Some studies suggest possible benefits for certain digestive and infant conditions, but evidence is still limited and varies by strain. It is generally well tolerated in healthy people, but anyone with a weak immune system or serious illness should check with a doctor or pharmacist first.

Bifidobacterium breve · Bifidobacteriaceae · Live bacterial cells (probiotic strain) · Capsules, powders, sachets, chewables, drops, and fortified foods or drinks

An interaction check asks whether these two react with each other — it does not ask whether Bifidobacterium Breve is a good idea for someone in your situation. Here is what our Bifidobacterium Breve record says about it on its own.

Bifidobacterium Breve: dosing

There is no single standard dose of Bifidobacterium breve. Probiotic amounts are usually measured in colony-forming units (CFU), and products vary widely in their strain and strength.The best approach is to follow the directions on the product label, since dosing was often based on the specific strain studied.

From our Bifidobacterium Breve monograph — the full record covers uses, side effects and every documented interaction.

Read the full Bifidobacterium Breve monograph & all interactions
Medication

About Temozolomide

What Is Temozolomide Used For?

Brand name: Temodar

Temozolomide treats two types of aggressive brain tumors in adults: glioblastoma and anaplastic astrocytoma. For newly diagnosed glioblastoma, it is given alongside radiation therapy and then continued as maintenance treatment.

For anaplastic astrocytoma, Temodar (the brand-name injection/capsule product) is approved for adjuvant treatment of newly diagnosed cases as well as refractory cases (tumors that have stopped responding to other treatment). Temozolomide Capsules, USP are approved for newly diagnosed glioblastoma and for refractory anaplastic astrocytoma in patients whose disease progressed on a regimen containing nitrosourea and procarbazine.

Most-Reported Side Effects for Temozolomide

From FAERS, the FDA’s public side-effect reporting system (20,946 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Disease progression 1,887 reports
Thrombocytopenia 1,569 reports
Nausea 1,310 reports
Fatigue 1,037 reports
Neutropenia 1,035 reports
See full Temozolomide drug information
Keep checking

Other Drugs & Bifidobacterium Breve

Browse every other medication we’ve checked against Bifidobacterium Breve — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
182Moderate
0Minor
2,647No known interaction
Moderate

182 interactions

Showing 60 of 182 moderate interactions — see all 182 on the Bifidobacterium Breve page.

No interaction 2,647 drugs checked — show the list
Evidence & sources

Bifidobacterium Breve References

The 9 references that drive our Bifidobacterium Breve monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  3. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  4. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81. PubMed
  5. Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
  6. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  7. Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
  8. Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667. PubMed
  9. Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014;28:1-3. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Bifidobacterium Breve and Temozolomide Together: Common Questions

Is it safe to take Bifidobacterium Breve with Temozolomide?
We do not list a known interaction between Bifidobacterium Breve and Temozolomide. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Bifidobacterium Breve and Temozolomide have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Should I take Bifidobacterium Breve and Temozolomide at the same time of day?
At least one FDA label for a product containing Temozolomide says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Temozolomide on its own and move Bifidobacterium Breve to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
How was the Bifidobacterium Breve and Temozolomide combination checked?
Interactions in our licensed database are recorded against drug classes. Temozolomide is filed under 3 classifications, and Bifidobacterium Breve has documented interactions with 1 drug class — none of Temozolomide's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Bifidobacterium Breve interact with any other medications?
Yes. Bifidobacterium Breve has 182 documented drug interactions in our database — Temozolomide is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Temozolomide interact with any supplements?
Yes. Temozolomide has documented interactions with 25 supplements in our database — Bifidobacterium Breve is not one of them. The Temozolomide interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Temozolomide and Bifidobacterium Breve?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.